Philips expands CV partnership
Lenox Hill Hospital has signed a two-year research alliance with Philips Medical Systems to collaborate on the development of advanced cardiovascular interventional technology. The collaboration will involve Philips' Allura Xper FD10 cardiac
Lenox Hill Hospital has signed a two-year research alliance with Philips Medical Systems to collaborate on the development of advanced cardiovascular interventional technology. The collaboration will involve Philips' Allura Xper FD10 cardiac catheterization lab and StentBoost, a stent imaging interventional tool. Much of the work will be done in the Lenox Hill Heart and Vascular Institute of New York City. The new collaboration, the outgrowth of a 15-year partnership between Lenox and Philips, will focus on a new image processing algorithm and how it can be used with the Allura Xper FD10 cath lab. The goal is to provide enhanced images of the heart that show lesions in greater detail. Philips' StentBoost will also be evaluated to assess its utility in stent placement.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
